Adding defibrillation therapy to cardiac resynchronization on the basis of the myocardial substrate

S Barra, S Boveda, R Providência, N Sadoul… - Journal of the American …, 2017 - jacc.org
Background: Patients with nonischemic dilated cardiomyopathy (DCM) may be at lower risk
for ventricular arrhythmias compared with those with ischemic cardiomyopathy (ICM). In …

A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: a prospective multi-centre randomized controlled trial (the …

AJA McLellan, LH Ling, S Azzopardi… - European heart …, 2015 - academic.oup.com
Aims Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation of atrial fibrillation
(AF). The intervenous ridge (IVR) may be incorporated into ablation strategies to achieve …

Coronary artery spasm and ventricular arrhythmias

KL Looi, A Grace, S Agarwal - Postgraduate medical journal, 2012 - academic.oup.com
Coronary artery spasm (CAS) is characterised by chest pain at rest and transient ST
segment elevation on the ECG. The natural history of variant angina is not fully understood …

Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy

S Barra, KL Looi, PR Gajendragadkar, FZ Khan… - EP …, 2016 - academic.oup.com
Abstract Aims The Goldenberg risk score, comprising five clinical risk factors (New York
Heart Association class> 2, atrial fibrillation, QRS duration> 120 ms, age> 70 years, and …

Cardiac resynchronisation therapy: pacemaker versus internal cardioverter-defibrillator in patients with impaired left ventricular function

KL Looi, PR Gajendragadkar, FZ Khan, M Elsik… - Heart, 2014 - heart.bmj.com
Objective Studies have shown beneficial effects of cardiac resynchronisation therapy (CRT)
on mortality among patients with heart failure. However the incremental benefits in survival …

Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator

KL Looi, A Tang, S Agarwal - Postgraduate Medical Journal, 2015 - academic.oup.com
In the era of widespread use of implantable cardioverter-defibrillators (ICDs) for both primary
and secondary prevention of sudden cardiac death, a significant proportion of patients …

Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure

S Barra, R Providência, R Duehmke, S Boveda… - Heart, 2017 - heart.bmj.com
Objective Among primary prevention patients with heart failure receiving cardiac
resynchronisation therapy (CRT), the impact of additional implantable cardioverter …

Long-term outcomes (> 2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation

KL Looi, P Gajendragadkar, T Taha, M Elsik… - Journal of Interventional …, 2013 - Springer
Purpose Catheter ablation for paroxysmal atrial fibrillation (PAF) is an effective treatment.
Favourable outcomes at 6–12 months post-ablation have been reported using the multi …

Long‐term outcomes of heart failure patients who received primary prevention implantable cardioverter‐defibrillator: an observational study

KL Looi, K Sidhu, L Cooper, L Dawson… - Journal of …, 2018 - Wiley Online Library
Background Implantable cardioverter‐defibrillator (ICD) therapy is indicated for selected
heart failure patients for the primary prevention of sudden cardiac death. Little is known …

Conscious sedation and analgesia use in cardiac device implantation

KL Looi, ASY Lee, K Cole… - International …, 2013 - internationaljournalofcardiology.com
Written informed consent for the procedures was obtained. Patient participation for the
questionnaire was voluntary. Verbal informed consent was obtained as per the ethics …